» Articles » PMID: 36291328

Embryonic Deletion of TXNIP in GABAergic Neurons Enhanced Oxidative Stress in PV+ Interneurons in Primary Somatosensory Cortex of Aging Mice: Relevance to Schizophrenia

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Oct 27
PMID 36291328
Authors
Affiliations
Soon will be listed here.
Abstract

The brain is susceptible to perturbations of redox balance, affecting neurogenesis and increasing the risks of psychiatric disorders. Thioredoxin-interacting protein (TXNIP) is an endogenous inhibitor of the thioredoxin antioxidant system. Its deletion or inhibition suggests protection for a brain with ischemic stroke or Alzheimer's disease. Combined with conditional knockout mice and schizophrenia samples, we aimed to investigate the function of TXNIP in healthy brain and psychiatric disorders, which are under-studied. We found TXNIP was remarkedly expressed in the prefrontal cortex (PFC) during healthy mice's prenatal and early postnatal periods, whereas it rapidly decreased throughout adulthood. During early life, TXNIP was primarily distributed in inhibitory and excitatory neurons. Contrary to the protective effect, the embryonic deletion of TXNIP in GABAergic (gamma-aminobutyric acid-ergic) neurons enhanced oxidative stress in PV interneurons of aging mice. The deleterious impact was brain region-specific. We also investigated the relationship between TXNIP and schizophrenia. TXNIP was significantly increased in the PFC of schizophrenia-like mice after MK801 administration, followed by oxidative stress. First episode and drug naïve schizophrenia patients with a higher level of plasma TXNIP displayed severer psychiatric symptoms than patients with a low level. We indicated a bidirectional function of TXNIP in the brain, whose high expression in the early stage is protective for development but might be harmful in a later period, associated with mental disorders.

Citing Articles

Gene expression differences associated with alcohol use disorder in human brain.

Willis C, White J, Minto M, Quach B, Han S, Tao R Mol Psychiatry. 2024; .

PMID: 39394458 DOI: 10.1038/s41380-024-02777-1.

References
1.
Hu H, Gan J, Jonas P . Interneurons. Fast-spiking, parvalbumin⁺ GABAergic interneurons: from cellular design to microcircuit function. Science. 2014; 345(6196):1255263. DOI: 10.1126/science.1255263. View

2.
Radonjic N, Knezevic I, Vilimanovich U, Kravic-Stevovic T, Marina L, Nikolic T . Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Neuropharmacology. 2009; 58(4-5):739-45. DOI: 10.1016/j.neuropharm.2009.12.009. View

3.
Ramli N, Yahaya M, Tooyama I, Damanhuri H . A Mechanistic Evaluation of Antioxidant Nutraceuticals on Their Potential against Age-Associated Neurodegenerative Diseases. Antioxidants (Basel). 2020; 9(10). PMC: 7588884. DOI: 10.3390/antiox9101019. View

4.
Barron H, Hafizi S, Andreazza A, Mizrahi R . Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci. 2017; 18(3). PMC: 5372663. DOI: 10.3390/ijms18030651. View

5.
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J . Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2009; 11(2):136-40. DOI: 10.1038/ni.1831. View